Wellcome Genome Campus
About the Campus
The Wellcome Genome Campus is home to some of the world’s foremost institutes and organisations in genomics and computational biology, committed to delivering life-changing science with the reach, scale and imagination to solve some of humanity’s greatest challenges.
Collectively, we believe that to seek and find solutions to humanity’s greatest challenges demands a bold and imaginative approach.
We bring together a diverse and exceptional scientific community who rise to those challenges, in a culture and environment that fosters creativity and rewards bold, ambitious thinking.
As a community, we are committed to delivering science with the reach, scale and imagination to deliver significant scientific and technical advances and incisive breakthroughs.
For more information about the Campus and its future vision, current job opportunities as well as information on the companies based at the BioData Innovation Centre, visit the Campus website.
Campus Leadership and Governance
The Wellcome Genome Campus is operated by Genome Research Limited (GRL), a registered Charity and wholly owned subsidary of Wellcome.
The Chief Executive Officer of Wellcome Genome Campus is Professor Sir Mike Stratton, who has devolved responsibility from Genome Research Limited to operate the Campus.
The Chief Operating Officer of Wellcome Genome Campus is Martin Dougherty, responsible for the overall management and operation of the Campus.
Genome Research Ltd
Genome Research Limited (GRL) is a wholly-owned subsidiary of the Wellcome and is legally responsible for the management of the Campus site, as well as all the activities of the Sanger Institute. Genome Research Limited’s Board of Directors delegates responsibility to the CEO of the Campus, Mike Stratton. He is accountable to the Director of Wellcome. Operational management of the Campus is delegated to the Campus Development Board which is Chaired by the COO, Martin Dougherty.